TikTok, DOJ Reach $400 Million Children’s Privacy Settlement 
Shein Launches $1.77 Billion Hong Kong IPO After Years of Listing Delays 
Anthropic IPO Could Challenge SpaceX’s Record $86 Billion Offering 
SpaceX Hires Natural Gas Trader to Meet Growing Energy Needs 
China EV Stocks Slide as Door Handle Recall Hits 4.3 Million Vehicles 
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse 
J.P. Morgan Upgrades Diploma, Lifts Price Target to 8,250p 
Exxon, LyondellBasell Eye Shell’s $8 Billion U.S. Chemicals Assets 
SK Hynix Shares Fall as Workers Reject Wage Deal 
Xiaomi Unveils Xring O3 Chip for Flagship Foldable Phone 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
SoftBank Plans Record $6.3 Billion Bond Sale to Fund OpenAI Investments 
Apple Cuts Over 200 Siri, Vision Pro Jobs in AI Shift 
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny 
California Seeks Paramount Divestitures in Warner Bros. Merger 
Nvidia AI Server Prices Set to Rise as Memory Costs Surge 
Nvidia Eyes Perplexity Investment at $30 Billion Valuation 
Add as a preferred source on Google
DALLAS, May 03, 2018 -- via OTC PR WIRE--Puration, Inc. (USOTC:PURA) today released an image of the packaging design for THCSavor, the THC infused beverage the company has planned for production in Canada in conjunction with a previously announced pending acquisition intended to establish a cannabis cultivation operation for the recreational marijuana market expected to be legalized nationwide in Canada this summer.
|
|||||
“This packaging is a work in progress,” Said Brian Shibley, CEO of Puration. “Feel free to email us and tell us what you think. I’m enthusiastic about our new partners in Canada and look forward to sharing more details with you after we close the Canadian acquisition.”
Puration has scheduled a shareholder presentation for, Thursday next week, on May 10th, to provide overall details on the Canadian business acquisition expected to be closed as early as the end of this week. Highlights of the THCSavor go-to-market plan are to be included in the upcoming shareholder presentation.
For more information on Puration, visit http://www.aciconglomerated.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
[email protected]
+1-800-861-1350
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/e769673c-f1aa-43fe-83dd-011a22393299
